All News

    What the Changing Seasons Taught Me About Cancer and Life

    September 16th 2025, 9:00pm

    Article

    The first day of fall comes on September 22, and every year it feels like a reminder to pause.

    Understanding the Importance of Biomarker Testing in Lung Cancer

    September 16th 2025, 8:00pm

    Video

    Dr. Joshua K. Sabari sat down with Terri Conneran at the 2025 World Conference on Lung Cancer for a conversation on the importance of biomarker testing.

    How to Individually Tailor Myelofibrosis Treatment Options

    September 16th 2025, 7:00pm

    Article

    Dr. Prithviraj Bose explains how doctors tailor myelofibrosis treatments and how patients can work with their care teams to navigate options.

    A Day in the Life of a Breast Cancer Survivor

    September 16th 2025, 5:00pm

    Article

    Since being diagnosed with breast cancer, my life has drastically changed. Time has helped each day become more precious and has caused me to become more grateful.

    Jakafi for Myelofibrosis Associated With Skin Cancer, Shingles Risk

    September 16th 2025, 4:00pm

    Article

    For patients with myelofibrosis, there is a risk of non-melanoma skin cancer or shingles among patients who received long-term treatment with Jakafi.

    FDA Grants Designation to Investigational Drug for Head and Neck Cancer

    September 16th 2025, 3:00pm

    Article

    The FDA has granted fast track designation to the investigational drug CRB-701 for recurrent or metastatic head and neck squamous cell carcinoma.

    Can Anemia or Bleeding Be a Sign of Gastrointestinal Stromal Tumors?

    September 16th 2025, 1:00pm

    Video

    Dr. Rosario Ligresti explained that while many GISTs are found incidentally, larger tumors may cause anemia, bleeding or swallowing issues.

    Thanking My Support System From My Cancer Journey

    September 15th 2025, 9:00pm

    Article

    Five years after being diagnosed with colon cancer, I would like to share how my support system continues to play a role in my life after active treatment.

    Ibtrozi May Address Unmet Needs In ROS1-Positive Non-Small Cell Lung Cancer

    September 15th 2025, 8:00pm

    Video

    Dr. Geoffrey Liu discussed findings from the phase 2 TRUST-II clinical trial evaluating Ibtrozi (taletrectinib) among patients with ROS1-positive non-small cell lung cancer.

    Actively Recruiting Trials for Lung, Biliary, AML and Small Cell Cancer

    September 15th 2025, 7:00pm

    Article

    Early trial results report progression-free survival and response rates for ateganosine, spevatamig, Annamycin and pumitamig; studies are currently enrolling.